Antilipemic and anti-inflammatory compositions containing sulfonate
申请人:Taiho Pharmaceutical Company Limited
公开号:US04489091A1
公开(公告)日:1984-12-18
Novel sulfonate derivatives represented by the formula R.sub.1 SO.sub.3 CH.sub.2 CO(CH.sub.2).sub.n R.sub.2 act to inhibit esterases and chymotripsin and are useful as antilipemic agents, anti-inflammatory agents, immunity controlling agents, etc.
Method of treating hyperlipidemia and inflammation with sulfonate
申请人:Taiho Pharmaceutical Company, Limited
公开号:US04411911A1
公开(公告)日:1983-10-25
Novel sulfonate derivatives represented by the formula R.sub.1 SO.sub.3 CH.sub.2 CO(CH.sub.2).sub.n R.sub.2 act to inhibit esterases and chymotripsin and are useful as antilipemic agents, anti-inflammatory agents, immunity controlling agents, etc.